Samir Machour
| Samir Machour | |
|---|---|
 Samir_Machour.jpg | |
| Born | October 10, 1963 Rabat, Morocco |
| 🏳️ Nationality | Moroccan-Canadian |
| 🏫 Education | University of Montreal (BSc) Concordia University (MSc) Harvard University (Executive Education) |
| 💼 Occupation | Biopharmaceutical executive, strategic investor, philanthropist |
| 📆 Years active | 1985–present |
| Known for | Leadership in vaccine self-reliance, global health manufacturing, and pandemic response |
Samir Machour (born October 10, 1963) is a Moroccan-Canadian biopharmaceutical executive, investor, and philanthropist, internationally recognized for his leadership in vaccine self-reliance, biologics manufacturing, and global health advancement. He gained prominence for directing Morocco’s COVID-19 vaccine procurement and rollout strategy, which enabled one of the fastest and most effective vaccination campaigns in Africa and positioned the country as a continental model of healthcare resilience.[1][2]
Early life and education
Machour was born in Rabat, Morocco, and raised between Errachidia and Rabat. He completed his secondary education at Lycée Tarik Ibn Ziyad in Azrou, where he earned his Baccalauréat in Experimental Sciences. In 1980, he moved to Canada to pursue higher education.[3]
He earned a Bachelor of Science in Physics from the University of Montreal, followed by a Master of Science in Nuclear Physics from Concordia University in Montreal, Quebec. Later in his career, he attended Harvard University, completing the General Management Program at Harvard Business School and additional executive programs at the Harvard Kennedy School of Government and Harvard Medical School.[3]
Career
Early industry roles
Machour’s career spans more than three decades across the pharmaceutical, biotechnology, and MedTech industries. He held senior leadership roles with several multinational companies, including Pfizer, GlaxoSmithKline, Johnson & Johnson, Becton Dickinson, and Boehringer Ingelheim.[3] In these positions, he oversaw operations, global supply chain management, regulatory compliance, and strategic business development.
Lonza Group
At the Swiss multinational Lonza Group, Machour played a key role in initiating discussions that led to Lonza’s $5.5 billion acquisition of Capsugel, the largest acquisition in the company’s history. His early involvement in framing strategic dialogues helped shape the deal, significantly expanding Lonza’s capabilities in pharmaceutical development and delivery and strengthening its position as a global leader in integrated manufacturing solutions.[4]
Samsung Biologics
In 2019, Machour joined Samsung Biologics in South Korea as Executive Vice President and Chief Quality Officer. He was later appointed to the company’s Executive Committee, where he oversaw global quality assurance, quality control, and regulatory compliance across all production sites. Under his leadership, the company became one of the world’s largest biologics contract development and manufacturing organizations.[5]
Machour directed the implementation of advanced quality management systems and maintained continuous readiness for inspections from major regulatory bodies, including the United States Food and Drug Administration, the European Medicines Agency, and Japan’s Pharmaceuticals and Medical Devices Agency. His work positioned Samsung Biologics as an international benchmark for manufacturing quality, operational integrity, and compliance excellence.[5]
Leadership during the COVID-19 pandemic
During the global vaccine shortage in 2020, Machour played a decisive role in Morocco’s COVID-19 response. Acting in close coordination with the Moroccan government, he led the negotiation, sourcing, and delivery of vaccines from international manufacturers. His leadership enabled Morocco to launch its vaccination campaign on January 28, 2021, ahead of most African countries and many nations in Europe and North America.[6]
Machour also presented to King Mohammed VI a long-term strategy for vaccine and biologics manufacturing sovereignty, leading to the construction of one of Africa’s largest vaccine fill-and-finish facilities. This initiative marked a major milestone in Morocco’s pursuit of pharmaceutical self-sufficiency and healthcare sovereignty.[6]
Bio Investments Group
Machour serves as Chairman and Chief Executive Officer of Bio Investments Group, headquartered in Zug, Switzerland. He leads projects focused on localizing the development and production of vaccines, biologics, and in vitro diagnostics across Africa and the Middle East. The company partners with governments, research institutions, and industry leaders to transfer advanced technologies, establish regional manufacturing hubs, and develop sustainable healthcare infrastructure.[2]
The group’s mission is to reduce dependency on imported medicines by building regional pharmaceutical capacity and supporting public health resilience. Under Machour’s leadership, Bio Investments Group has become a key driver of healthcare self-reliance initiatives in the Global South.[7]
Altruist Biologics
Machour serves as Executive Chairman of Altruist Biologics, based in Hangzhou, China. The company is one of Asia’s largest integrated biologics platforms, specializing in contract development, manufacturing, and innovation partnerships. His leadership strengthened Altruist’s international collaboration networks and reinforced its role in global biopharmaceutical supply chains.[8][9]
Personal life
Machour resides in Seoul, South Korea. Outside his professional activities, he dedicates time to mentorship, education, and philanthropic initiatives promoting healthcare equity and capacity building in emerging markets. His career reflects a lifelong commitment to science, leadership, and the advancement of public health.[9]
Philanthropy and educational initiatives
Executives Without Borders
In 2007, while studying at Harvard Business School, Machour founded Executives Without Borders, a nonprofit organization dedicated to applying business expertise to humanitarian and development challenges. The organization brings together senior executives to design and implement sustainable projects addressing health, education, and environmental needs in developing regions.[6]
One of its most impactful programs, the Ramase Lajan initiative in Haiti, established a community-based recycling network that created over 1,000 jobs, reduced plastic waste, and improved local sanitation. The project has been recognized internationally as a model of sustainable economic empowerment and social innovation.[2]
George Mason University Korea Scholarship
Machour serves on the Advisory Board of George Mason University Korea, supporting global education and leadership development. In 2022, he established the Sam Machour Scholarship Endowment to assist talented students from underrepresented backgrounds, promoting education as a foundation for opportunity and social progress.[5]
Awards and recognition
Machour has been featured by international media outlets including Bloomberg, Reuters, and the South China Morning Post for his contributions to vaccine access and global health manufacturing. In 2018, he received the Top 50 Healthcare Leaders Award at the Smart Health Conference in Dubai for his impact on global pharmaceutical development and manufacturing innovation.[4]
References
- ↑ https://www.bignewsnetwork.com/news/278747271/bridging-continents-through-biotech-samir-machour-mission-for-a-healthier-world
- ↑ 2.0 2.1 2.2 https://economicweeklynews.org/transforming-global-health-systems-inside-the-vision-of-samir-machour
- ↑ 3.0 3.1 3.2 https://www.moroccoworldnews.com/2021/01/62548/samir-machour-unsung-hero-who-helped-morocco-secure-covid-19-vaccines/
- ↑ 4.0 4.1 https://newsdipper.co.uk/sam-machour-redefining-global-health-leadership
- ↑ 5.0 5.1 5.2 https://speromagazine.com/building-health-sovereignty-the-global-leadership-of-samir-machour/
- ↑ 6.0 6.1 6.2 https://bradleyadam.livepositively.com/science-sovereignty-and-service-samir-machouraos-blueprint-for-health-independence/
- ↑ https://medium.com/@bradley.adam/samir-machour-and-the-new-era-of-vaccine-manufacturing-in-africa-and-asia-60406b616760
- ↑ https://theusacorner.com/global-impact-through-local-strength-the-story-of-samir-machours-bio-investments-vision/
- ↑ 9.0 9.1 https://rodney-25.livejournal.com/15201.html
